BE

Heartbeam IncNASDAQ BEAT Stock Report

Last reporting period 30 Sep, 2023

Updated 22 Nov, 2024

Last price

Market cap $B

0.054

Micro

Exchange

XNAS - Nasdaq

BEAT Stock Analysis

BE

Uncovered

Heartbeam Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.054

Dividend yield

Shares outstanding

8.01 B

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 5 full-time employees. The company went IPO on 2021-10-14. The company specializes in cardiovascular diagnostic technology. The company is primarily focused on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company focuses on providing diagnostic data to help physicians with care management of patients with cardiovascular disease. The company delivers remote diagnostic and monitoring technologies that can be used for patients anywhere for ambulatory and emergency room (ER) use. Its telehealth product is comprised of a credit card-sized Electrocardiogram (ECG) machine and a cloud-based diagnostic software system. The company is applying its platform technology to create a software tool for detecting heart attacks in the ED environment. This software tool is designed to enable emergency physicians to diagnose heart attacks. Its credit card sized cardiac electrical signal collection device captures cardiac signals that represent projections of the heart vector.

View Section: Eyestock Rating